Latest news

Filter by
Date
Mar 11, 2018 10:00 AM

Major funding boost for prostate cancer in NSW

A new $3.75 million collaborative project aims to accelerate personalised approaches to prostate cancer treatment – and is part of a total package of $12 million awarded to cancer researchers at Garvan and across NSW.

MEDIA RELEASE: Aug 23, 2017 06:00 AM

Ground-breaking trial brings personalised treatments to thos...

Garvan's Genomic Cancer Medicine Program, launched today by The Hon. Brad Hazzard, uses genomic medicine to match therapies, prevention and screening methods with rare cancer patients based on their genetic information.

MEDIA RELEASE: Aug 04, 2017 01:00 AM

Top-to-toe MRI screen picks up early-stage cancers while sti...

A major study shows that whole-body MRI screening can identify previously undetected primary tumours throughout the body in people with high genetic risk of cancer.

MEDIA RELEASE: Aug 05, 2016 08:35 AM

Beyond ‘single-gene thinking’: Garvan researchers uncover co...

In a landmark multi-country study, Australian researchers have transformed our understanding of the genes that affect our risk of cancer.